CareDx, Inc. (CDNA)
CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing donor-derived cell-free DNA (dd-cfDNA) technology to assess the health of kidney, heart, and lung transplants, respectively. AlloMap Heart: A gene expression-based solution specifically for heart transplant patients. AlloSeq cfDNA: A broader surveillance tool to measure dd-cfDNA levels in the blood. CareDx also provides cutting-edge human leukocyte antigen (HLA) typing technologies, such as TruSight HLA, an NGS-based high-resolution typing solution; Olerup SSP, which uses sequence-specific primer technology for HLA allele typing; QTYPE for precise HLA typing; and AlloSeq Tx, another high-resolution HLA typing offering. For stem cell transplant recipients, the company offers AlloSeq HCT for chimerism testing. Beyond diagnostics, CareDx develops vital software and digital platforms to streamline transplant patient management. These include Ottr, a dedicated transplant patient management software; XynQAPI, focused on transplant quality tracking and waitlist management; and AlloCare, a mobile application serving as a patient-centric resource for those who have undergone transplantation. The company distributes its products directly to clients, as well as through a network of third-party distributors and sub-distributors. CareDx has forged significant partnerships, including a licensing agreement with Illumina, Inc. for the distribution, development, and commercialization of next-generation sequencing (NGS) products and technologies. Additionally, it collaborates with Cibiltech SAS to commercialize iBox, a software designed for the predictive analysis of kidney allograft loss post-transplantation. Founded in 1998, the company was initially known as XDx, Inc. before rebranding to CareDx, Inc. in March 2014. Its headquarters are located in South San Francisco, California.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
CareDx, Inc
NASDAQ:CDNAHealthcare · Medical - Diagnostics & Research
+22.22%$87.41
AH$87.81+0.46%vs close
Mkt Cap$4.59B
Float50.19M
O/S52.54M
Vol
$ Vol
RVOL
Inst Own99.9%
SI13.4%
Earnings
Dilution
Financials Summary
Revenue$379.81M
Net Income-$21.35M
Total Assets$413.23M
Free Cash Flow$36.12M
Debt & Equity
Debt 8%
Equity 92%
Total Debt$26.19M
Total Equity$303.1M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in CDNA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$413.23M
Liabilities$110.13M
Accounts Receivable$42.63M
Accounts Payable$9.99M
Inventory$26.7M
PP&E (Net)$55.73M
Goodwill$40.34M
Intangible Assets$31.96M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $379.81M | $333.79M | $280.32M | $321.79M | $296.4M | $192.19M | $127.07M | $76.57M | $48.32M | $40.63M | $28.14M | $27.31M | $22.1M | $20.45M |
| YoY Growth | 13.8% | 19.1% | -12.9% | 8.6% | 54.2% | 51.3% | 66.0% | 58.4% | 18.9% | 44.4% | 3.1% | 23.6% | 8.1% | - |
| Cost of Revenue | $123.24M | $109.63M | $102M | $112.21M | $97.39M | $63.12M | $45.45M | $32.99M | $21.37M | $21.12M | $10.27M | $8.54M | $9.08M | $7.93M |
| Gross Profit | $256.57M | $224.16M | $178.32M | $209.58M | $199.01M | $129.08M | $81.61M | $43.58M | $26.95M | $19.51M | $17.87M | $18.77M | $13.02M | $12.52M |
| Gross Margin | 67.6% | 67.2% | 63.6% | 65.1% | 67.1% | 67.2% | 64.2% | 56.9% | 55.8% | 48.0% | 63.5% | 68.7% | 58.9% | 61.2% |
| Research and Development | $71.43M | $72.41M | $81.87M | $90.39M | $76.53M | $48.94M | $30.71M | $14.51M | $12.39M | $12.38M | $9.33M | $3.85M | $3.18M | $4.75M |
| Selling, General, and Administrative | $210.21M | $205.5M | $201.2M | $196.42M | $152.21M | $102.66M | $75.43M | $43.63M | $31.72M | $31.89M | $20.6M | $14.91M | $10.7M | $10.11M |
| Other | $0 | -$94.52M | $98.62M | $0 | $0 | $0 | $0 | -$178K | $0 | $0 | -$188K | $147K | $0 | -$14K |
| Total Operating Expenses | $281.64M | $183.39M | $381.69M | $286.81M | $228.73M | $151.6M | $106.14M | $58.14M | $44.11M | $44.28M | $29.93M | $18.75M | $13.88M | $14.86M |
| Operating Income (EBIT) | -$25.07M | $40.77M | -$203.36M | -$77.23M | -$29.73M | -$22.53M | -$24.53M | -$15.58M | -$20.29M | -$37.33M | -$11.93M | $1.25M | -$857K | -$2.34M |
| Operating Margin | -6.6% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | -91.9% | -42.4% | 4.6% | -3.9% | -11.5% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.7M | $5.86M | $1.86M | $1.59M | $2.12M | $2.15M | $2.7M |
| Interest Income | $9.17M | $11.77M | $11.87M | $3.76M | $160K | $271K | $985K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $3.99M | $12.09M | $13.22M | $997K | -$2.36M | $2.78M | $585K | -$32.64M | -$36.98M | -$4.03M | -$1.77M | -$1.97M | -$2.69M | -$2.72M |
| Income Before Tax (EBT) | -$21.08M | $52.86M | -$190.14M | -$76.23M | -$32.09M | -$19.75M | -$23.95M | -$48.22M | -$57.27M | -$41.36M | -$13.71M | -$719K | -$3.54M | -$5.06M |
| Income Tax Expense | $271K | $310K | $141K | $379K | -$1.43M | -$1.04M | -$1.98M | -$1.43M | -$1.71M | -$1.61M | $0 | -$1.5M | $0 | $0 |
| Net Income | -$21.35M | $52.55M | -$190.28M | -$76.61M | -$30.66M | -$18.71M | -$21.97M | -$46.76M | -$55.47M | -$39.47M | -$13.71M | $781K | -$3.54M | -$5.06M |
| Net Income Margin | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% | -9.7% | -17.3% | -61.1% | -114.8% | -97.1% | -48.7% | 2.9% | -16.0% | -24.7% |
| Supplementary Data | ||||||||||||||
| EPS | -0.40 | 1.00 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | -1.31 | -2.38 | -2.39 | -1.16 | 0.13 | -0.48 | -0.69 |
| Diluted EPS | -0.40 | 0.93 | -3.54 | -1.44 | -0.59 | -0.40 | -0.52 | -1.31 | -2.38 | -2.39 | -1.16 | 0.10 | -0.48 | -0.69 |
| Weighted Average OS | 53.29M | 52.77M | 53.76M | 53.32M | 52.24M | 46.48M | 42.15M | 35.64M | 23.31M | 16.50M | 11.82M | 5.82M | 7.37M | 7.37M |
| EBITDA | -$4.66M | -$33.99M | -$84.92M | -$60.23M | -$20.2M | -$8.17M | -$17.39M | -$11.36M | -$14.61M | -$17.85M | -$11.26M | $523K | -$194K | -$1.27M |
| EBITDA Margin | -1.2% | -10.2% | -30.3% | -18.7% | -6.8% | -4.3% | -13.7% | -14.8% | -30.2% | -43.9% | -40.0% | 1.9% | -0.9% | -6.2% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $65.43M | $114.69M | $82.2M | $89.92M | $348.49M | $134.67M | $38.22M | $64.62M | $16.89M | $17.26M | $29.89M | $36.43M | $5.13M | $5.83M |
| Short-Term Investments | $111.78M | $145.96M | $153.22M | $203.17M | $0 | $90.03M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $177.21M | $260.65M | $235.42M | $293.09M | $348.49M | $224.7M | $38.22M | $64.62M | $16.89M | $17.26M | $29.89M | $36.43M | $5.13M | $5.83M |
| Accounts Receivable | $42.63M | $64.61M | $51.06M | $66.31M | $59.76M | $34.62M | $24.06M | $9.76M | $2.99M | $2.77M | $2.37M | $2.69M | $2.27M | $952K |
| Inventory | $26.7M | $19.5M | $19.47M | $19.23M | $17.19M | $10.01M | $6.01M | $4.94M | $5.53M | $5.46M | $766K | $686K | $518K | $576K |
| Other Current Assets | $10.59M | $7.07M | $7.76M | $9.22M | $0 | $0 | $0 | $1.79M | $1.35M | $1.19M | $1.34M | $542K | $0 | $0 |
| Total Current Assets | $257.13M | $351.83M | $313.71M | $387.85M | $433.36M | $273.1M | $71.92M | $81.11M | $26.77M | $26.67M | $34.36M | $40.35M | $8.17M | $7.61M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $55.73M | $57.89M | $65.14M | $70.22M | $40.04M | $25.93M | $9.16M | $4.13M | $2.08M | $2.93M | $2.42M | $1.97M | $1.55M | $2.12M |
| Goodwill | $40.34M | $40.34M | $40.34M | $37.52M | $36.98M | $23.86M | $23.86M | $12.01M | $12.01M | $13.84M | $12.01M | $12.01M | $0 | $0 |
| Intangible Assets | $31.96M | $38.18M | $45.7M | $43.05M | $50.2M | $44.35M | $45.54M | $33.25M | $33.14M | $33.12M | $6.65M | $6.65M | $0 | $0 |
| Long-Term Investments | $24.16M | $0 | $0 | $0 | $0 | $0 | $0 | $192K | $9.58M | $143K | $147K | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.49M | $2.64M | $2.94M | -$147K | $0 | $0 | $0 |
| Other Long-Term Assets | $3.9M | $2.81M | $1.94M | $4.35M | $6.05M | $1.27M | $1.26M | -$3.49M | -$2.64M | -$2.92M | $196K | $172K | $149K | $152K |
| Total Long-Term Assets | $156.1M | $139.22M | $153.11M | $155.14M | $133.26M | $95.41M | $79.81M | $49.58M | $56.8M | $50.06M | $21.28M | $20.8M | $1.7M | $2.27M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $413.23M | $491.05M | $466.83M | $542.99M | $566.62M | $368.51M | $151.74M | $130.7M | $83.56M | $76.73M | $55.64M | $61.14M | $9.87M | $9.88M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $9.99M | $7.69M | $12.87M | $9.94M | $13.34M | $9.65M | $5.51M | $4.71M | $3.39M | $3.06M | $1.64M | $1.13M | $618K | $637K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $15.72M | $22.85M | $2.87M | $5.96M | $4.46M | $1.46M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $4.65M | $4.85M | $4.75M | $5.34M | $4.21M | $24.03M | $3.69M | $39K | $39K | $42K | $142K | $505K | $80K | $813K |
| Other Current Liabilities | $41.61M | $41.12M | $26.24M | $21.3M | $32.77M | $21.2M | $15.39M | $9.16M | $18.77M | $5.82M | $2.9M | $202K | $860K | $2.45M |
| Total Current Liabilities | $89.85M | $89.37M | $78.07M | $75.97M | $77.3M | $69.22M | $34.83M | $19.5M | $42.91M | $40.83M | $10.15M | $11.13M | $7.59M | $6.44M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $18.34M | $1.1M | $12.89M | $5.45M | $10.91M | $13.41M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $691K | $730K | $759K | $703K | $471K | $1.62M | $0 |
| Long-Term Deferred Tax Liabilities | $181K | $164K | $136K | $0 | $415K | $1.3M | $1.97M | $2.97M | $4.93M | $6.06M | $1.43M | $1.68M | $0 | $0 |
| Other Long-Term Liabilities | $418K | $819K | $99.01M | $2.7M | $5.63M | $4.25M | $13.56M | $11.61M | $22.61M | $8.22M | $2.4M | $2.79M | $140.42M | $137.23M |
| Total Long-Term Liabilities | $20.28M | $23.25M | $127.43M | $36.1M | $23.44M | $21.61M | $17.91M | $15.27M | $46.61M | $16.14M | $15.99M | $8.71M | $152.95M | $150.64M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $110.13M | $112.62M | $205.5M | $112.08M | $100.75M | $90.83M | $52.74M | $34.77M | $89.52M | $56.97M | $26.14M | $19.84M | $160.55M | $157.08M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $135.73M | $135.2M |
| Common Stock | $50K | $51K | $49K | $52K | $52K | $49K | $42K | $41K | $29K | $21K | $12K | $12K | $1K | $1K |
| Retained Earnings | -$735.36M | -$626.24M | -$678.27M | -$460.44M | -$383.19M | -$352.53M | -$333.81M | -$311.85M | -$268.02M | -$212.55M | -$173.08M | -$159.38M | -$160.16M | -$156.61M |
| Comprehensive Income & Other | -$5.51M | -$8.57M | -$6.96M | -$7.5M | -$4.67M | -$2.1M | -$5.21M | -$4.28M | -$2.35M | -$3.66M | -$11.87M | -$11.09M | -$10.9M | -$10.33M |
| Other Stockholders' Equity | $1.04B | $1B | $939.55M | $891.3M | $849.01M | $630.16M | $432.77M | $407.73M | $261.86M | $232.01M | $202.56M | $200.66M | $9.48M | $9.41M |
| Total Equity | $303.1M | $378.43M | $261.33M | $430.91M | $465.88M | $277.68M | $99M | $95.93M | -$6.13M | $19.48M | $29.49M | $41.3M | -$150.67M | -$147.2M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $180K | $279K | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $413.23M | $491.05M | $466.83M | $542.99M | $566.62M | $368.51M | $151.74M | $130.7M | $83.39M | $76.45M | $55.64M | $61.14M | $9.87M | $9.88M |
| Supplementary Data | ||||||||||||||
| Total Debt | $26.19M | $28.37M | $34.22M | $39M | $21.35M | $18.1M | $5.39M | $172K | $34.06M | $23.94M | $15.75M | $11.41M | $15.42M | $14.92M |
| Net Debt | -$39.23M | -$86.32M | -$47.98M | -$50.92M | -$327.13M | -$116.57M | -$32.84M | -$64.44M | $17.16M | $6.69M | -$14.13M | -$25.02M | $10.29M | $9.09M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$21.35M | $52.55M | -$190.28M | -$76.61M | -$30.66M | -$18.71M | -$21.97M | -$46.78M | -$55.56M | -$39.76M | -$13.71M | $781K | -$3.54M | -$5.06M |
| Depreciation & Amortization | $20.42M | $19.76M | $19.82M | $16.01M | $11.88M | $9.54M | $7.14M | $4.21M | $3.76M | $2.92M | $796K | $512K | $663K | $1.07M |
| Deferred Income Tax | $17K | -$187K | $566K | $0 | $0 | $0 | $0 | -$1.61M | -$2.09M | -$1.34M | -$2K | -$1.5M | $525K | -$2K |
| Stock-Based Compensation | $34.86M | $66.41M | $49.09M | $46.55M | $36.08M | $23.4M | $22.42M | $7.14M | $1.74M | $2M | $1.34M | $535K | $72K | $69K |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $22.52M | -$13.74M | $16.02M | -$6.66M | -$24.42M | -$10.4M | -$12.68M | -$3.97M | -$109K | $1.05M | $320K | -$417K | -$1.32M | -$150K |
| Inventory | -$4.96M | -$1.02M | $54K | -$2.86M | -$6.93M | -$3.2M | -$1.27M | $363K | $1.02M | $492K | -$80K | -$168K | $58K | -$152K |
| Accounts Payable | $808K | -$5.11M | $2.9M | -$2.05M | $1.79M | $4.39M | $1.35M | -$168K | $292K | -$620K | $489K | $510K | -$19K | -$113K |
| Other Working Capital | -$14.56M | -$82.44M | $87.06M | -$2.64M | -$11.42M | $26.61M | $2.18M | $2.9M | -$2.34M | $552K | $1.1M | -$2.21M | $2.65M | $2.11M |
| Total Working Capital Change | $3.81M | -$102.31M | $106.03M | -$14.22M | -$40.97M | $17.4M | -$10.41M | -$871K | -$1.13M | $1.47M | $1.83M | -$2.29M | $1.38M | $1.7M |
| Other Non-Cash Items | $4.28M | $1.83M | -$3.61M | $3.03M | $4.37M | $1.8M | $51K | $33.9M | $38.97M | $18.18M | -$9K | -$1.39M | $360K | $447K |
| Net Cash from Operating | $42.03M | $38.05M | -$18.39M | -$25.24M | -$19.29M | $33.43M | -$2.77M | -$4.01M | -$14.31M | -$16.52M | -$9.75M | -$3.35M | -$546K | -$1.78M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | -$6.59M | -$6.48M | -$9.24M | -$24.33M | -$20.26M | -$10.36M | -$3.35M | -$7.24M | -$186K | -$549K | -$1.2M | -$733K | -$98K | -$141K |
| Acquisitions | $0 | $0 | -$6.68M | -$610K | -$15.43M | $0 | -$18.23M | -$692K | -$5.92M | -$20.57M | $0 | -$600K | $0 | $0 |
| Purchases of Investments | -$145.93M | -$160.29M | -$201.16M | -$315.14M | -$5.5M | -$90.03M | -$1M | $0 | -$59K | $0 | $0 | $0 | $0 | -$1.62M |
| Sales of Investments | $154.67M | $166.92M | $256.04M | $111.59M | $88.91M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.41M |
| Other Investing Activities | $0 | -$634K | $1.5M | $0 | $0 | $0 | $0 | -$5.2M | -$59K | -$20.57M | $0 | $0 | $0 | $783K |
| Net Cash from Investing | $2.16M | -$483K | $40.45M | -$228.5M | $47.71M | -$100.39M | -$22.58M | -$7.93M | -$6.16M | -$21.12M | -$1.2M | -$1.33M | -$98K | $642K |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | - | - | $66K | $183K | $172K | $13.81M | -$9.64M | $3.94M | -$4.16M | -$454K | $58K | -$1.66M |
| Common Stock Issuance | $8M | $0 | $0 | $0 | $188.85M | $158.13M | $0 | $52.91M | $18.33M | $28.55M | $203K | $39.25M | $0 | $0 |
| Common Stock Repurchases | -$87.77M | -$522K | -$27.54M | -$642K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$13.62M | -$5.08M | -$2.06M | -$3.89M | -$3.15M | $5.2M | $40K | $65.45M | $19.67M | $323K | $46K | $35.53M | $0 | $10K |
| Net Cash from Financing | -$93.39M | -$5.61M | -$29.61M | -$4.54M | $185.64M | $163.15M | -$132K | $50.27M | $29.38M | $24.93M | $4.41M | $35.99M | -$58K | $4.61M |
| Forex Effect | -$90K | $532K | -$112K | $23K | -$303K | $274K | -$849K | $2K | $104K | $83K | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$49.29M | $32.49M | -$7.66M | -$258.25M | $213.76M | $96.46M | -$26.33M | $38.33M | -$363K | -$12.63M | -$6.54M | $31.3M | -$702K | $3.47M |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | $42.03M | $38.05M | -$18.39M | -$25.24M | -$19.29M | $33.43M | -$2.77M | -$4.01M | -$14.31M | -$16.52M | -$9.75M | -$3.35M | -$546K | -$1.78M |
| Capital Expenditure | -$5.91M | -$6.48M | -$9.24M | -$24.33M | -$20.26M | -$10.36M | -$3.35M | -$7.24M | -$186K | -$549K | -$1.2M | -$733K | -$98K | -$141K |
| Free Cash Flow | $36.12M | $31.56M | -$27.63M | -$49.57M | -$39.55M | $23.07M | -$6.12M | -$11.24M | -$14.49M | -$17.07M | -$10.95M | -$4.08M | -$644K | -$1.92M |
| Cash at Beginning | $115.27M | $82.78M | $90.44M | $348.7M | $134.94M | $38.48M | $64.81M | $26.47M | $17.26M | $29.89M | $36.43M | $5.13M | $5.83M | $2.36M |
| Cash at End | $65.98M | $115.27M | $82.78M | $90.44M | $348.7M | $134.94M | $38.48M | $64.81M | $16.89M | $17.26M | $29.89M | $36.43M | $5.13M | $5.83M |